Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hip replacement patients monitored for years to improve future surgeries

NCT ID NCT07481448

Knowledge-focused Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study will follow 200 people who have had a complex or revision hip replacement at University Hospitals Leuven. The goal is to track how many need another surgery and why, and to improve care by learning from real-world results. No new treatment is being tested—this is an observational study to gather data for better surgical decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Mar 2037

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Every patient, regardless of sex or age, undergoing complex primary THA or aseptic revision hip arthroplasty, is eligible for inclusion in this study. This study will therefore also include children and women of childbearing age, although this is expected to be extremely rare. The decision on whether a primary hip replacement is categorized as a complex procedure is left to the discretion of the treating physician.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing a hip replacement for the following indications: 1. THA with hardware removal 2. THA for hip dysplasia 3. THA with femoral deformity or prior corrective surgery 4. THA after LCPD, SCFE or septic arthritis 5. THA in metabolic disease 6. THA in hyperlaxity (e.g. Ehlers-Danlos syndrome, Down syndrome) 7. THA with complex bony anatomy 8. THA in patients aged 25 years or younger 9. Other indications for which the treating surgeon expects increased surgical difficulty or increased risk of postoperative complications Exclusion Criteria: * Patients unable to provide written informed consent * Patients who prefer treatment outside of University Hospitals Leuven * Patients with proven PJI according to the 2021 EBJIS criteria * Patients undergoing standard, non-complex, hip replacement as judged by the treating physician.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip arthropathy associated with other conditions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

arthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip arthropathy associated with other conditions

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universitaire Ziekenhuizen KU Leuven

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium